UGT1A1 and UGT1A9 variants affect thyroxine glucuronidation in human livers.

被引：0
|
作者：
Graber, AY [1 ]
Innocenti, F [1 ]
Ramirez, J [1 ]
Chen, PX [1 ]
Das, S [1 ]
Ratain, MJ [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P73 / P73
页数：1
相关论文
共 50 条
  • [31] Glucuronidation of bavachinin by human tissues and expressed UGT enzymes: Identification of UGT1A1 and UGT1A8 as the major contributing enzymes
    Lv, Xia
    Hou, Jie
    Xia, Yang-Liu
    Ning, Jing
    He, Gui-Yuan
    Wang, Ping
    Ge, Guang-Bo
    Xiu, Zhi-Long
    Yang, Ling
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (05) : 358 - 365
  • [32] RACIAL DIFFERENCES IN THE ASSOCIATION BETWEEN UGT1A1*28 AND GENE EXPRESSION OF UGT1A1 AND SEARCHING FOR NOVEL REGULATORY VARIANTS OF UGT1A1
    Montalvo, A.
    Ferber, J.
    Collins, J.
    Wang, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S76 - S77
  • [33] Humanized UGT1*28 Mice for Assessing UGT1A1 dependent glucuronidation and Clearance
    Yang, Young-Sun
    Peterkin, Vincent
    Cai, Hongliang
    Hotz, Kathy
    Nguyen, Nghia
    La Placa, Deirdre
    Tukey, Robert H.
    Stevens, Jeffrey C.
    DRUG METABOLISM REVIEWS, 2009, 41 : 39 - 40
  • [34] In vitro glucuronidation of mycophenolic acid by human UGTs and the impact of known polymorphisms of UGT1A8, UGT1A9, and UGT2B7
    Bernard, O
    Guillemette, C
    DRUG METABOLISM REVIEWS, 2003, 35 : 53 - 53
  • [35] Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype
    Rauchschwalbe, SK
    Zühlsdorf, MT
    Wensing, G
    Kuhlmann, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2004, 42 (02) : 73 - 77
  • [36] UGT1A9 RS3832043 INFLUENCES ACETAMINOPHEN GLUCURONIDATION IN NEONATES
    Linakis, M. W.
    Liu, X.
    Cook, S. F.
    Kumar, S.
    Wilkins, D. G.
    Gaedigk, R.
    Gaedigk, A.
    Sherwin, C. M.
    van den Anker, J. N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S19 - S19
  • [37] Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7
    Antonio, L
    Xu, J
    Little, JM
    Burchell, B
    Magdalou, J
    Radominska-Pandya, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 411 (02) : 251 - 261
  • [38] UGT1A1*28 polymorphism influences glucuronidation of bazedoxifene
    Lusin, T. Trdan
    Mrhar, A.
    Trontelj, J.
    PHARMAZIE, 2015, 70 (02): : 94 - 96
  • [39] A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity
    Yamanaka, H
    Nakajima, M
    Katoh, M
    Hara, Y
    Tachibana, O
    Yamashita, J
    McLeod, HL
    Yokoi, T
    PHARMACOGENETICS, 2004, 14 (05): : 329 - 332
  • [40] Identification and Characterization of Oxymetazoline Glucuronidation in Human Liver Microsomes: Evidence for the Involvement of UGT1A9
    Mahajan, Mukesh K.
    Uttamsingh, Vinita
    Can, Liang-Shang
    Leduc, Barbara
    Williams, David A.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (02) : 784 - 793
12345